Novel Androgen Inhibitors Show Promise in Treatment of Prostate Cancer
University of Maryland, BaltimoreCastration has long been the primary strategy for the treatment of metastatic prostate cancer. However, researchers at the University of Maryland School of Medicine have identified new androgen inhibitors that they believe could supplant castration as the primary method of treatment.